Yale Biotech Club 2026 Bioinvestment & Venture Capital Program

Date: Thursday, January 15, 2026 - Monday, February 23, 2026
Time: 2:30pm - 3:30pm
Location: 165 Whitney Avenue, New Haven, CT 06511 - Yale School of Management
Learn more at yalebiotechclub.org/projects-1 …

The Yale Biotech Club is excited to announce the 2026 Bioinvestment & Venture Capital Program. 

Open to all Yale affiliates (current undergraduate and graduate students, alumni, staff, postdoc), this program is designed to give an introduction to the field of biotechnology investment and acquire the knowledge of how to break into the industry. Kicking off on January 15th, this program consists of a didactic in-person lecture series led by industry experts (see below for lecture list). Lectures will be 45-60 min long, followed by a 15 min Q+A session and a 15-30 min networking opportunity.

Here’s the lecture schedule with registration links:

Session 1: Bioinvestment & Venture Capital 101 Featuring Bryan Czyzewski, PhD; Managing Director, Jefferies

Thursday, January 15, 2:30 PM – 4:00 PM
Session Goal: Understand the overview of the biotech innovation ecosystem, funding stages, and key players

Session 2: Navigating Drug Development & FDA Regulatory Policies. Featuring Lee S Simon, MD; Former FDA’s Division Director

Wednesday, January 21, 2:00 PM – 3:30 PM
​Session Goal: Understanding the clinical trial phases and key inflection points.

Session 3: Biotech’s Strategic Engine: Intellectual Property & Transactions. David Lewin, PhD; President, Life Science, Latent Alpha

Wednesday, February 4, 2:30 PM – 4:00 PM
​Session Goal: Understanding the clinical trial phases and key inflection points.

REGISTER HERE

Session 4: Biotech Due Diligence, Valuation & Risk Assessment. Megha Unhelkar, PhD; Director, Bioscience Investments, CT Innovations

Tuesday, February 10, 2:30 PM – 4:00 PM
​Session Goal: Learn how to evaluate deals and understand uncertainties. Build investor skillsets including due diligence, and financial valuation.
Session 5: Strategic Growth & Exit Pathways Featuring Ranjit Bindra, MD PhD; Professor at Yale, Serial Biotech Entrepreneur. 
Monday, February 23, 2:30 PM – 3:30 PM
​Session Goal: Examine exit pathways:  licensing deals, IPOs, and M&A and understand how exit strategies shape VC returns and company strategy.

Tags: OCS Partner Events, Biotech and Pharma, Entrepreneurship, Startups, and Venture Capital, Exploring Careers, Intellectual Property, Technology Transfer, and Patent Law, STEM PhD Pathways Program

Add to Calendar

Google Calendar Outlook/iCal